24/7 Helpline: +1 626 539 9760

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.


Compared with ordinary preparations, sustained-release medicine has the advantages of fewer administration times, smaller fluctuations in blood drug concentration, diversified administration routes, less irritation, long-lasting curative effect, and safety. At present, this type of preparation has attracted more and more attention.


Driven by downstream demand and product advantages have become the main driving factors for the industry. However, high barriers, high costs, and inflexible dosage have become the main restraints of the market development.


The global Sustained-release Medicine market is valued at US$ 34.85 billion in 2022. The market size will reach US$ 55.05 billion by the end of 2029, growing at a CAGR of 6.89% during 2023-2029.


In terms of regions, North America and Europe holds the largest share of the global market in 2022 owing to factors such as continuous investment in R&D and numerous local leading pharmaceutical companies. Future forecast the market in Asia Pacific is expected to grow at the highest CAGR during the forecast period, with the development of the pharmaceutical industry and increasing R&D and investment in developing countries.


In terms of competition, the global Sustained-release Medicine market is highly fragmented. The global major players of Sustained-release Medicine include, Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, etc. In terms of revenue, the global five largest players hold a 31.21% market share of Sustained-release Medicine in 2022.


The market for sustained-release medicines has seen increased competition in recent years, with more pharmaceutical companies developing and manufacturing these types of medications.


Also, there are smaller companies and startups entering the market and developing new treatments. This has led to increased innovation and more options for patients.

The market for original and generic medicines has evolved over time, with changes in the manufacturing and marketing trends of each type of medicine. Original ground medicine is typically developed by large pharmaceutical companies that invest significant resources in research and development, clinical trials, and regulatory approval. These companies have exclusive rights to sell the medicine for a certain period of time, during which they can charge high prices to recoup their investment and generate profits.


But the market for generic medicines has grown significantly in recent years, as patents for many popular medicines have expired and allowed other companies to manufacture and sell cheaper generic versions. This has led to increased competition and lower prices for these medicines, making them more accessible to patients.


Many generic medicines are now produced by large multinational companies that have invested in manufacturing capabilities in countries with lower labor costs. This has enabled them to produce high-quality medicines at lower prices, and has contributed to the growth of the global generic drug market.


Read More Information:


About Us:

QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:

62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)

7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)

300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)

2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)

1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)

30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)

15 + Years focus market research and continues to support the client success.


Media Contact:

Rahul Singh - Digital Marketing Director

Contact: +91 7028 920 828



Sales Contact US:

USA Registered Office: QY Research, INC. 

17890 Castleton, Suite 369,

City of industry, CA - 91748

Emails –

Web –

©2007-2026 QY Research All Rights Reserved.